SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-178836
Filing Date
2024-07-15
Accepted
2024-07-15 08:03:35
Documents
18
Period of Report
2024-07-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d869775d8k.htm   iXBRL 8-K 70578
6 GRAPHIC g869775g00w01.jpg GRAPHIC 58283
7 GRAPHIC g869775g00w02.jpg GRAPHIC 69501
8 GRAPHIC g869775g00w03.jpg GRAPHIC 117107
9 GRAPHIC g869775g00w04.jpg GRAPHIC 47651
  Complete submission text file 0001193125-24-178836.txt   910370

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rvmdw-20240715.xsd EX-101.SCH 4426
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvmdw-20240715_def.xml EX-101.DEF 13415
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmdw-20240715_lab.xml EX-101.LAB 22307
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmdw-20240715_pre.xml EX-101.PRE 14319
20 EXTRACTED XBRL INSTANCE DOCUMENT d869775d8k_htm.xml XML 5898
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 241115896
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)